VANLENT ANNE
Insider CIK 1229243 · ONTX Director · AGTC Director · TZYM Director · AEGR Director · TRVI Director · BOTA Director · NVLN Director · IART Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 16,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 8,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 14,210 | — | $0 | 14,210 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 12,700 | — | $0 | 12,700 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 47,807 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 107,977 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 20,983 | — | $0 | 20,983 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 5,000 | $10.00 | $50.0K | 25,983 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2019-05-07 | 2019-05-08 | 23,684 | — | $0 | 23,684 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-07-25 | 2018-07-27 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-07-25 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 10,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 12,500 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 2,652 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 2,083 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 10,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 20,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 12,500 | $1.52 | $19.0K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2017-06-20 | 2017-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AVIR Aviragen Therapeutics, Inc | A Award deriv | 2017-05-18 | 2017-05-22 | 20,000 | $0.49 | $9.8K | 105,000 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2017-02-28 | 2017-03-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2016-12-22 | 2016-12-27 | 9,600 | — | $0 | 9,600 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 14,700 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 5,012 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 18,000 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer | 2016-11-29 | 2016-11-30 | 4,000 | — | $0 | 0 | SEC↗ |
| NVLN QLT INC/BC | A Award | 2016-11-29 | 2016-12-01 | 4,102 | — | $0 | 4,102 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2016-08-17 | 2016-08-18 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-06-14 | 2016-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AVIR Aviragen Therapeutics, Inc | A Award deriv | 2016-05-12 | 2016-05-13 | 20,000 | $1.50 | $30.0K | 20,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | A Award deriv | 2015-08-11 | 2015-08-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-06-26 | 2015-06-29 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | P Buy | 2015-06-22 | 2015-06-24 | 35,000 | $2.20 | $77.0K | 35,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2015-06-15 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | A Award deriv | 2015-05-12 | 2015-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-06-26 | 2014-06-30 | 5,012 | — | $0 | 5,012 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2014-05-22 | 2014-08-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | A Award deriv | 2014-05-15 | 2014-05-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-05-08 | 2014-05-09 | 52 | $35.29 | $1.8K | 4,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-05-08 | 2014-05-09 | 1,948 | $34.33 | $66.9K | 3,948 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-05-08 | 2014-05-09 | 2,000 | $33.20 | $66.4K | 2,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-08-30 | 2013-12-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2013-07-25 | 2013-07-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2013-07-25 | 2013-07-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | A Award deriv | 2013-05-01 | 2013-05-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-04-26 | 2013-04-30 | 14,700 | — | $0 | 14,700 | SEC↗ |
| TZYM TRANZYME INC | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| IART INTEGRA LIFESCIENCES HOLDI | A Award | 2012-05-17 | 2012-05-21 | 2,500 | — | $0 | 8,478 | SEC↗ |